Chad Vanderbilt, Assistant Member and Pathologist at Memorial Sloan Kettering Cancer Center, shared on LinkedIn:
”NeurIPS 2026 Workshop (Sydney) – ASCI Call for Papers and Speaker Announcement
We are pleased to announce ASCI – AI at Scale for Clinical Impact: Cancer Pathology Foundation Models, a NeurIPS 2026 workshop at the International Convention Centre Sydney (December 11 – 12, 2026; exact day to be confirmed).
ASCI brings together researchers, clinicians, and industry teams working on cancer AI models that can move from technical benchmarks to validated clinical impact, with emphasis on hospital-scale learning, multimodal clinical data, evaluation, translation into practice, and related topics.
Call for papers
- Abstract registration (required): August 20, 2026, 12:00 AM UTC
- Full paper deadline: August 29, 2026, 12:00 AM UTC
- Accept / reject decision: September 29, 2026
Speakers
Thomas Fuchs, Hoifung Poon, Piotr Bojanowski, Jana Lipkova, Ruijiang Li, Jakob Nikolas Kather, Bo Wang, Danielle Bitterman, Nigam Shah, Jorge Reis-Filho.
Organizers
Neeraj Kumar, Gabriele Campanella, Ruchika Verma, Jia Wu, Jianjun Zhang, Luisa M. Solis Soto, Rukhmini Roy, Muhammad Waqas Sheikh, H.R. Tizhoosh, Wataru Uegami, Saghir Alfasly, Joel Saltz, Jakub Kaczmarzyk, Kostas Triaridis, Melissa Troester, Siddharth Singi, and Katherine Hoadley.
Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, UT MD Anderson, Mayo Clinic, Stony Brook University, The University of North Carolina at Chapel Hill.”
You can also read ‘Artificial Intelligence in Cancer Immunotherapy‘
